CA150 represses RNA polymerase II (RNAPII) transcription by inhibiting the elongation of transcripts. The FF repeat domains of CA150 bind directly to the phosphorylated carboxyl-terminal domain of the largest subunit of RNAPII. We determined that this interaction is required for efficient CA150-mediated repression of transcription from the ␣ 4 -integrin promoter. Additional functional determinants, namely, the WW1 and WW2 domains of CA150, were also required for efficient repression. A protein that interacted directly with CA150 WW1 and WW2 was identified as the splicing-transcription factor SF1. Previous studies have demonstrated a role for SF1 in transcription repression, and we found that binding of the CA150 WW1 and WW2 domains to SF1 correlated exactly with the functional contribution of these domains for repression. The binding specificity of the CA150 WW domains was found to be unique in comparison to known classes of WW domains. Furthermore, the CA150 binding site, within the carboxyl-terminal half of SF1, contains a novel type of proline-rich motif that may be recognized by the CA150 WW1 and WW2 domains. These results support a model for the recruitment of CA150 to repress transcription elongation. In this model, CA150 binds to the phosphorylated CTD of elongating RNAPII and SF1 targets the nascent transcript.A complex array of general transcription factors, DNA binding activators and repressors, and a multitude of coregulators mediate transcription in eukaryotes (32,48,49). Regulation of the frequency of transcription initiation is a well-documented means of controlling gene expression (32,48,64), but many genes are also controlled by modulation of the ability of RNA polymerase II (RNAPII) to elongate transcripts (11, 15-17, 37, 53, 82, 93). Although the mechanisms controlling RNAPII elongation efficiency are not completely understood, it is clear that the interplay of multiple protein factors regulates RNAPII elongation efficiency (21,70,75). Some of these elongation factors have been identified, and they belong to two classes: positive transcription elongation factors (P-TEFs), such as positive elongation factor b (P-TEFb) (38,47,67,68), and negative transcription elongation factors (N-TEFs), such as DRB sensitivity-inducing factor (DSIF) and negative elongation factor (NELF) (28,84,90). In addition to trans-acting elongation factors, nucleic acid sequences in the template and transcript can modulate elongation (11,44,82). A topic central to elongation control is the role of the carboxyl-terminal domain (CTD) of the largest subunit of RNAPII (25). The CTD contains 52 repeats of a 7-amino-acid sequence with the consensus YSPTSPS and is the substrate for several kinases, including P-TEFb (25,68,99). Phosphorylation of the CTD occurs during a transitional step of the transcription cycle, the switch from the initiation phase to the elongation phase. Hypophosphorylated RNAPII (designated RNAPIIA) is preferentially recruited to a promoter and initiates transcription. Subsequently, the RNAPII becomes hyper...